HopeStage
Back to all studies
RecruitingNCT06671977

Studying DMT in people with depression and healthy volunteers

About this titleRead the official source — NCT06671977
Medication studyAges 21–65United States
The study in practice

Understand this study

Who could participate?

Listed age limits: 21 years to 65 years.

Listed locations
West HavenSee all locations and recruitment
Study phase
Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: March 14, 2025
Recruitment status
Recruiting
Enrollment listed in the registry
60
Sponsor
Deepak C. D'Souza
Sponsor type
Individual investigator
Study type
Drug
Intervention type
Drug
Study phase
Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
Locations
United States
Age range
From 21 Years to 65 Years
Official registry ID
NCT06671977
Official title
Show the full official title

Phase 1 Study of the Safety, Tolerability, Electrophysiological Effects and Efficacy of DMT in Humans

Recruitment & locations

Currently recruiting

West Haven

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Deepak C. D'Souza.

Does this study involve medication?

Yes. The study involves medication, including DMT-Medium Dose, DMT-Low Dose, THC-Medium Dose and THC-Low Dose.

Who can participate?

Listed age limits: 21 years to 65 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies